Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Share-based Compensation (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Share-based Compensation for 9 consecutive years, with $28.1 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 3.58% to $28.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $130.4 million through Dec 2025, up 12.48% year-over-year, with the annual reading at $130.3 million for FY2025, 12.29% up from the prior year.
  • Share-based Compensation hit $28.1 million in Q4 2025 for Inspire Medical Systems, down from $29.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $41.7 million in Q2 2025 to a low of $6.0 million in Q1 2021.
  • Historically, Share-based Compensation has averaged $20.3 million across 5 years, with a median of $20.7 million in 2023.
  • Biggest five-year swings in Share-based Compensation: soared 118.43% in 2021 and later dropped 3.58% in 2025.
  • Year by year, Share-based Compensation stood at $7.0 million in 2021, then surged by 113.81% to $15.0 million in 2022, then soared by 52.01% to $22.8 million in 2023, then increased by 27.36% to $29.1 million in 2024, then dropped by 3.58% to $28.1 million in 2025.
  • Business Quant data shows Share-based Compensation for INSP at $28.1 million in Q4 2025, $29.5 million in Q3 2025, and $41.7 million in Q2 2025.